All Cancer Microbiology articles – Page 2
-
NewsGut microbiome and tumor cachexia: New European research network
EU project ‘MiCCrobioTAckle’ aims to investigate the complex interactions between the gut microbiome and the human body in order to find ways of slowing down muscle breakdown in tumor cachexia, while promoting young scientists for microbiota medicine.
-
NewsCircadian disruption and gut microbiome changes linked to colorectal cancer progression
Research has revealed how disruption of the circadian clock, the body’s internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function.
-
NewsBacteria involved in gum disease linked to increased risk of head and neck cancer
More than a dozen bacterial species among the hundreds that live in people’s mouths have been linked to a collective 50% increased chance of developing head and neck squamous cell carcinoma (HNSCC), a new study shows. Some of these microbes had previously been shown to contribute to ...
-
NewsFecal DNA testing could reduce global colonoscopy burden: experts
Experts gathered at the ICG 19 · Metagenomics for Health (ICG19·MH) & The 2nd MOHA Consortium have highlighted the global challenge of limited access to colonoscopy, the gold standard for CRC screening.
-
News‘Transient’ gut bacteria may affect health and guide diet choices
‘Transient’ populations of gut bacteria may contribute to the development of chronic liver disease and diabetes, but a personalised diet plan could lessen the risk, new research suggests.
-
NewsGut bacteria influence responses to immunotherapy in patients with asbestos related cancer
A cancer study has found that certain gut bacteria may influence whether or not a patient’s immune system is successful in fighting mesothelioma, an aggressive form of cancer.
-
NewsSkin fungus colonization accelerates breast cancer tumor growth
A common skin fungus, Malassezia globosa may invade deep tissues through the skin or by other means, then cause tumor growth, according to a new study.
-
NewsFirst narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum in breakthrough study
Scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates Fusobacterium nucleatum without harming the oral or gut microbiomes.
-
NewsResearchers take inspiration from viruses to improve delivery of nucleic acid-based therapies to cancer cells
A researcher is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.
-
NewsNew study reveals metabolites key to faster intestinal recovery for cancer patients
A collaborative study has uncovered how metabolites drive communication between gut microbes and human cells to aid intestinal recovery after chemotherapy. This research offers new hope for enhancing cancer treatment outcomes.
-
NewsSphingomyelins (TFSM) can visualise Chlamydia inclusions within infected human cells
Researchers have succeeded in developing a sphingomyelin derivative that can be used to visualise the distribution of sphingomyelin and the activity of sphingomyelinase in infection processes.
-
NewsInnovations in cancer treatment through targeted bacterial vaccines
Scientists outline efforts to create an antibacterial vaccine capable of eliciting robust immune responses to selectively eradicate Fusobacterium nucleatum while preserving other microbiota.
-
NewsNew vaccine against cervical cancer combines prophylactic and therapeutic activity
Scientists at the German Cancer Research Center (DKFZ) have developed a completely new vaccination concept with a new vaccine against cancer-causing human papillomaviruses (HPV).
-
NewsGut microbes implicated in bladder cancer
A new study shows that gut bacteria can metabolise carcinogens and cause them to accumulate in distant organs, leading to tumour development.
-
NewsStudy says new drug shows promise in clearing HIV from brain
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study.
-
NewsFecal matter transplant helped patients with gastrointestinal cancers overcome resistance to immunotherapy treatment
Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers.
-
NewsPanel issues first guidelines to prevent anal cancer in people with HIV
Results from a national study have informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
-
NewsStudy shows ancient viruses fuel modern-day cancers
When reawakened, endogenous retroviruses can play a critical role in helping cancer survive and thrive. A new study also suggests that silencing certain endogenous retroviruses can make cancer treatments work better.
-
NewsResearchers develop noninvasive urine test for early detection of cervical cancer virus proteins
A new urine test can detect HPV16 E7 proteins, which are critical markers of cervical cancer risk, at extremely low levels, meaning women may be able to screen for cervical cancer without the discomfort and inconvenience of a traditional Pap test.
-
CareersConnecting with microbiologists and presenting research: Oluwole Owoyemi reports back from ASM 2024
Medical microbiologist Oluwole Owoyemi of Achievers University Owo and Federal University of Technology, Akure, reports back from ASM MICROBE 2024 after being awarded a Scientific Event Travel Grant by Applied Microbiology International.
